As Saia (SAIA) Stock Price Rose, Shareholder Brant Point Investment Management Cut Stake by $1.38 Million; Brahman Capital Continues to Hold Stake in Teva Pharmaceutical Inds LTD (TEVA)

Teva Pharmaceutical Industries Limited (NYSE:TEVA) Logo

Brahman Capital Corp increased its stake in Teva Pharmaceutical Inds Ltd (TEVA) by 67.26% based on its latest 2018Q4 regulatory filing with the SEC. Brahman Capital Corp bought 4.93 million shares as the company’s stock declined 23.31% while stock markets rallied. The hedge fund held 12.25M shares of the major pharmaceuticals company at the end of 2018Q4, valued at $188.87 million, up from 7.32 million at the end of the previous reported quarter. Brahman Capital Corp who had been investing in Teva Pharmaceutical Inds Ltd for a number of months, seems to be bullish on the $17.99 billion market cap company. The stock increased 0.24% or $0.04 during the last trading session, reaching $16.51. About 6.63M shares traded. Teva Pharmaceutical Industries Limited (NYSE:TEVA) has declined 11.23% since March 17, 2018 and is downtrending. It has underperformed by 15.60% the S&P500. Some Historical TEVA News: 25/04/2018 – FDA: Abbreviated New Drug Application (ANDA): 209824 Company: TEVA PHARMS USA; 03/05/2018 – TEVA PHARMACEUTICAL INDUSTRIES LTD – RAISING 2018 FULL YEAR GUIDANCE; 29/05/2018 – Top research execs from Teva, Allergan recruited to help lead Axovant out of the R&D wasteland $AXON $AGN $TEVA; 26/03/2018 – Teva Announces the Launch of a Generic Version of Lialda in the United States; 23/05/2018 – TEVA PHARMACEUTICAL INDUSTRIES – CONFIRMED THAT FDA EXTENDED GOAL DATE OF BLA FOR FREMANEZUMAB; 13/03/2018 – TEVA CFO MICHAEL MCCLELLAN SPEAKS AT ANALYST CONFERENCE; 19/04/2018 – TEVA PHARMACEUTICAL-CONFIRMS CO, P&G INTEND TO DISSOLVE PGT HEALTHCARE PARTNERSHIP, SET UP TO MARKET COMPANIES’ OVER-THE-COUNTER MEDICINES, LATER THIS YEAR; 15/05/2018 – Florida Lawsuit Targets Painkiller Makers Purdue Pharma, Endo Pharmaceuticals, Johnson & Johnson, Teva Pharmaceutical and Allergan; 24/05/2018 – AMARIN – TEVA MAY FIRST BEGIN SELLING ITS GENERIC VERSION OF VASCEPA IN U.S. ON AUGUST 9, 2029, OR EARLIER UNDER CERTAIN CUSTOMARY CIRCUMSTANCES; 24/05/2018 – AMARIN CORPORATION – ANNOUNCED SETTLEMENT AGREEMENT WITH TEVA PHARMACEUTICALS USA THAT RESOLVES AMARIN’S PREVIOUSLY REPORTED VASCEPA PATENT LITIGATION

Brant Point Investment Management Llc decreased its stake in Saia Inc (SAIA) by 35.72% based on its latest 2018Q4 regulatory filing with the SEC. Brant Point Investment Management Llc sold 25,000 shares as the company’s stock rose 3.56% with the market. The hedge fund held 44,995 shares of the transportation company at the end of 2018Q4, valued at $2.51 million, down from 69,995 at the end of the previous reported quarter. Brant Point Investment Management Llc who had been investing in Saia Inc for a number of months, seems to be less bullish one the $1.61 billion market cap company. The stock decreased 1.82% or $1.16 during the last trading session, reaching $62.7. About 191,703 shares traded. Saia, Inc. (NASDAQ:SAIA) has declined 9.24% since March 17, 2018 and is downtrending. It has underperformed by 13.61% the S&P500. Some Historical SAIA News: 14/05/2018 – Oak Ridge Adds Saia, Exits Maximus, Cuts AO Smith: 13F; 27/04/2018 – SAIA 1Q EPS 80C, EST. 72C; 27/04/2018 – Saia Inc. 1Q Net Income Doubles; 17/04/2018 – Saia LTL Freight Joins CargoNet Program; 05/04/2018 – Saia to Relocate New Jersey Terminal; 01/05/2018 – Saia Opens Second Seattle-area Terminal; 27/04/2018 – Saia 1Q EPS 80c; 27/03/2018 – AcelRx announces appointment of John Saia as General Counsel; 27/04/2018 – Saia 1Q Rev $392.8M; 27/04/2018 – SAIA 1Q REV. $393M, EST. $383.0M

Brant Point Investment Management Llc, which manages about $798.12 million and $688.34 million US Long portfolio, upped its stake in Zoetis Inc (NYSE:ZTS) by 67,521 shares to 87,521 shares, valued at $7.49M in 2018Q4, according to the filing. It also increased its holding in Spdr Series Trust (KRE) by 93,058 shares in the quarter, for a total of 182,358 shares, and has risen its stake in Vail Resorts Inc (NYSE:MTN).

More notable recent Saia, Inc. (NASDAQ:SAIA) news were published by: Globenewswire.com which released: “Saia to Announce Fourth Quarter 2018 Results on February 4, 2019 – GlobeNewswire” on January 10, 2019, also Globenewswire.com with their article: “Saia Boston-area Terminals Now Open Nasdaq:SAIA – GlobeNewswire” published on December 10, 2018, Nasdaq.com published: “SAIA Makes Bullish Cross Above Critical Moving Average – Nasdaq” on February 19, 2019. More interesting news about Saia, Inc. (NASDAQ:SAIA) were released by: Globenewswire.com and their article: “Saia Increases and Extends Credit Facility Nasdaq:SAIA – GlobeNewswire” published on February 06, 2019 as well as Nasdaq.com‘s news article titled: “Saia, Inc. (SAIA) Shares March Higher, Can It Continue? – Nasdaq” with publication date: February 21, 2019.

Analysts await Saia, Inc. (NASDAQ:SAIA) to report earnings on April, 26. They expect $0.92 earnings per share, up 19.48% or $0.15 from last year’s $0.77 per share. SAIA’s profit will be $23.56M for 17.04 P/E if the $0.92 EPS becomes a reality. After $0.97 actual earnings per share reported by Saia, Inc. for the previous quarter, Wall Street now forecasts -5.15% negative EPS growth.

Brahman Capital Corp, which manages about $4.97 billion and $1.73 billion US Long portfolio, decreased its stake in Iqvia Hldgs Inc by 38,148 shares to 1.88M shares, valued at $218.22M in 2018Q4, according to the filing. It also reduced its holding in Hilton Worldwide Hldgs Inc by 28,870 shares in the quarter, leaving it with 1.43 million shares, and cut its stake in Gci Liberty Inc.

More notable recent Teva Pharmaceutical Industries Limited (NYSE:TEVA) news were published by: Seekingalpha.com which released: “Teva Pharmaceutical beats by $0.13, misses on revenue – Seeking Alpha” on November 01, 2018, also Seekingalpha.com with their article: “UBS sees 38% upside for Teva in permarket analyst action – Seeking Alpha” published on March 07, 2019, Finance.Yahoo.com published: “Why Teva’s Outlook Is Mixed – Yahoo Finance” on August 23, 2018. More interesting news about Teva Pharmaceutical Industries Limited (NYSE:TEVA) were released by: Seekingalpha.com and their article: “MannKind – Scripts, Sponsorships, Warrants – MannKind Corporation (NASDAQ:MNKD) – Seeking Alpha” published on March 16, 2019 as well as Benzinga.com‘s news article titled: “Credit Suisse Lifts Teva (NYSE:TEVA) Price Target, Says Execution Is Key For Migraine Drug – Benzinga” with publication date: September 17, 2018.

Saia, Inc. (NASDAQ:SAIA) Institutional Positions Chart